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Introduction 
 
The European Union has to take account of technological progress 
in sectors with high value added, not only within the borders of the 
Member States that constitute the Single Market but also in its 
near-abroad, the Euro-Mediterranean region.   Protecting the fruits 
of innovation, in economic terms, means that companies with 
specialized know-how which sells branded goods and patented 
products or processes have a competitive advantage when it comes 
to maintaining or expanding their market share. Among the 
essential criteria for the effective protection of innovation in 
Europe, the most important are ease of obtaining patents, legal 
certainty, cost-effectiveness and appropriate geographic coverage. 
 
In pharmaceuticals and plant-health products, in biotechnological 
inventions, in the protection of new plant varieties, as well as in 
software related inventions, promoting and protecting innovation 
through patents is an important matter for Europe, as a response to 
the need for creating a viable and strong economy.  Comprising the 
whole continent and the neighboring regions, Europe needs further 
steps to overcome its main global competitors, since the existing 
patent system in Europe is quite complicated as it is: national 
patents exist alongside European patents; the Community patent 
system has yet to come into operation.    Companies doing business 
within the European Union still do not have access to a single 
system of patent protection.  Thus, the patent system for protecting 
innovation in Europe exists along a two-tier route, with national 
patents surviving alongside European patents. And it is soon 
expected to turn into a three-tier route, with the Community patents 
system in progress. 
 
The Union should seek to remove all the political and practical 
obstacles that remain, preventing as they do the single market from 
  383realizing its full potential.  And in its need to create more jobs by 
increasing the international competitiveness of European 
companies and to overcome the pressures resulting from the 
globalisation of the economy, the European Union should 
strengthen ties in respect to the adoption of the acquis 
communautaire in the area of patent protection not only with the 
countries of central and eastern Europe but also with those of the 
south and east of the Mediterranean. 
 
Innovation is fundamental to economic growth, and research and 
development (R&D) which is at the heart of the growth mechanism 
of modern market economies, can generate innovation across 
space.  In the increasingly integrated European market, on the level 
of sub-national regions which are more homogeneous than 
countries, are better connected within themselves and are important 
policy units for research and innovation purposes, significant R&D 
spillovers diffuse within 300 km from the source region
1.  
  
The total number of patents granted to inventors residing in a 
region was used in order to measure that region’s innovative 
output.  Localized R&D spillovers were found to exist if the 
productivity of R&D in a region was affected by the amount of 
R&D resources used in other regions in spatial proximity.  New 
ideas are generated using R&D resources which are a private and 
excludable input, and existing ideas which are a public input or at 
least a locally public input into the innovative process. The codified 
part of a new idea is likely to be available to anyone who can read a 
patent, and therefore it is a fully public good.  Nevertheless, an 
important  part of the knowledge generated with the idea is linked 
to the experience of the scientists, who share a stock of increasing 
knowledge through personal contacts and face-to-face interactions.  
This kind of “local public good” benefits scientists within the 
region or its neighborhoods.  These findings on spillover effects of 
                                                 
1 R&D and innovation in 86 European Regions for the period 1977-1995 was 
studied by Laura Bottazzi and Giovanni Peri, in “Innovation and Spillovers in 
regions: Evidence from European patent data,” 17 October 2002, European 
Economic Review 47 [2003], 687-710. 
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Mediterranean that has close proximity to highly developed regions 
of the European Union. 
 
Patent Protection in Europe 
 
Patent protection for European countries can be obtained by filing 
several national applications at the respective national patent 
offices or by filing one European Patent Organisation (EPO) patent 
application at the European Patent Office (EPO), the “Office.”  The 
EPO application designates the European Patent Convention (EPC) 
member states for which patent protection is requested.  The 
European Patent Convention does not create a uniform protection 
right, but it provides the applicant with protection in as many of the 
signatory states as he wishes.  While the European Patent 
Convention is open to accession by any European state, the 
Administrative Council of the European Patent Organisation may 
also extend invitation for membership to other countries. (Article 
166 of the Convention). 
 
The European Patent Organisation (EPO) is the outcome of the 
European countries’ collective political determination to establish a 
uniform patent system in Europe.  The EPO is a centralised patent 
grant system, administered by the European Patent Office on behalf 
of all contracting states.  It is a model of successful cooperation in 
Europe.  It will be beneficial for all sectors of industry and business 
initiatives to extend the uniform European patent protection to the 
whole of the Mediterranean region, similar to the recent extension 
of protection towards the Central and Eastern European countries.  
 
The EPO comprises the Administrative Council, its legislative 
body, and the European Patent Office, its executive body which 
grants European patents for the contracting states to the EPC.  The 
Administrative Council, composed of delegates from the 
contracting states, supervises the activities of the EPO; the task of 
the Office is to grant European patents.  Even though EPO lacks a 
court with powers to settle patent disputes at European level, it 
allows for a centralised opposition process which works more 
  385effectively than having competent courts in the Member States 
handing down contradictory judgements. 
 
Patents issued by the EPO designate the European states in which 
the applicants wish to patent their inventions. The EPO patents 
have significant cost advantages for inventions requiring protection 
in a number of European markets, since EPO patent  applications 
cost roughly three times as much as national applications  in most 
European states.  The total cost of a European patent amounts to 
approximately Euro 29,800.  The official patent office fees are a 
relatively small part of the costs (in this case, Euro 4,300).   
Professional representation before the EPO amounts to Euro 5,500 
on average, while translation into the languages of eight contracting 
states requires Euro 11,500.  Renewal fees for a patent maintained 
for ten years amount to roughly Euro 8,500
2.  
 
If patent protection is sought for more than three designated states, 
the application for a European patent is less expensive than 
independent applications in several patent jurisdictions.  This cost 
advantage has made the EPO filing path particularly attractive for 
applicants selling goods and services in multiple European markets.  
Nevertheless, translations of the specifications have to be filed with 
the national patent office of each designated country and renewal 
fees have to be paid for each of those countries.  The sum total of 
the national fees payable for renewal of a European patent 
constitutes quite a heavy burden for patentees.  The additional costs 
of protection for each designated country prompt businesses to be 
selective in their choice of countries.  Often, requests for protection 
are concentrated on the larger European States, and this condition 
disadvantages the smaller ones in terms of both technology transfer 
and their attractiveness to investors.  For the EU, the limitation of 
protection to only part of the single market reduces the commercial 
value of the patented good or process. 
 
                                                 
2 See,  http://www3.european-patent-office.org/epo/new/kosten_e.pdf). 
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centralised legal challenge: under the European Patent Convention 
(EPC), any third party can use opposition proceeding to challenge 
the granted patent within nine months after the granting date for all 
of the designated states, rather than having to pursue legal 
proceedings in each of the European nations designated in the 
patent.  The EPO opposition process is a more effective means of 
ensuring “high quality” patents, especially in novel technology 
areas, than those available in the United States under the re-
examination procedure of US Patent and Trademark Office 
(USPTO)
3. 
  
EPO patent grants are issued for inventions that are novel, mark an 
inventive step, are commercially applicable, and are not excluded 
from patentability for other reasons.  Article 52 of EPC stipulates 
the “other reasons” for refusal of patent grant.  After the filing of an 
EPO application, a search report is made available by the EPO to 
the applicant.  The search report is generated by EPO’s search 
office in The Hague and then transferred to the examining staff in 
the Munich office.  The search report describes the state of prior art 
regarded as relevant according to EPO guidelines for the 
patentability of the invention. Unlike the US system, applicants at 
the EPO are not required to supply a full list of prior art including 
references to prior patents and/or non-patent sources
4.  
 
Applicants can request the examination of their application within 
six months after the announcement of the publication of the search 
report in the EP Bulletin.  Upon request of the examination, which 
is a compulsory prerequisite for the patent grant, the process 
continues until the EPO presents a report as a result of the 
examination.  Otherwise, the patent application is deemed to be 
                                                 
3 Stuart J.H. Graham, Bronwyn H. Hall, Dietmar Harhoff and David C. Mowery, 
“Post-Issue Patent ‘Quality Control’: A Comparative Study of US Patent Re-
Examinations and European Patent Opposition,” NBER Working Paper Series, 
No. 8807, February 2002,  JEL No. K 41, L 00, L 20;   
http://www.nber.org/papers/w8807, National Bureau of Economic Research. 
4 Ibid., “Post-Issue Patent ‘Quality Control’....p. 10. 
 
 
  387withdrawn.  Through the examination period, the patent owner is 
generally required to make some changes in the original 
application. Negotiations between the applicant and the EPO 
generally centre around the scope of the allowable subject matter 
and the claim(s) which define specifically the area for which 
exclusive rights are sought.  Thus the applicant may be required to 
reveal some relevant information about the invention prior to the 
grant of the patent. 
 
If priority is requested, this provides temporary protection in all the 
EPO member states for the invention related to the said application 
for the grant of a patent.  Eighteen months after the priority date, 
the patent application is published.  The issue of a European patent 
often takes about 4.2 years from the date of filing the application.  
When the EPO decides to grant a patent, the patent issues for the 
designated European states and is translated into the relevant 
national languages.  Any decisions made by the EPO receiving, 
examining, opposition sections and legal division can be appealed 
and the appeal has suspensive effect.  If the EPO declines to grant a 
patent, the applicant may file an appeal. 
 
Within nine months after the patent has been granted, any third 
party can oppose the European patent centrally at the European 
Patent Office by filing an opposition against the granting decision.  
Oppositions are lodged against around 6% of the European patents 
granted every year.  In special proceedings involving all the 
opposing parties, the EPO Opposition Division is called upon to 
decide whether the contested patent should be maintained, 
amended or revoked.   The outcome of the opposition procedure is 
binding for all designated states.  If opposition is not filed within 
nine months after the grant, the patent’s validity can only be 
challenged under the legal rules of the respective designated 
countries. 
 
In an opposition to a European patent, which is filed with the EPO, 
the opponent has to substantiate his opposition by presenting 
evidence that the prerequisites for patentability were not fulfilled.  
Allegations of the opponent might be that the invention lacked 
novelty and/or an inventive step, or that the disclosure was poor or 
  388insufficient. The Opposition Division of the EPO, which   
comprises three technically qualified members and one lawyer, 
determines the outcome.   
 
As a result of the opposition procedure, the patent may be upheld 
without any amendments, may be amended (a reduction of the 
“breadth” of the patent by altering the claims), or may be revoked.  
Once an opposition is filed, the opponent and patentholder are no 
longer free to settle their case outside of the EPO opposition 
process.  The EPO may even pursue the case on its own even if the 
opposition is withdrawn or in the event of legal incapacity of the 
opponent or lack of participation of the heirs.  This provision helps 
to discourage the use of the opposition proceeding by opponents 
who may seek to force patentholders to licence their patents.   
 
The parties have the right to appeal against the decision of the 
Opposition Division before an EPO Technical Board of Appeal.  
The appeal against the outcome of the opposition procedure must 
be filed within two months after receipt of the decision of the 
opposition chamber of the EPO. The appeal of either the 
patentholder(s) or the opponent(s) must be substantiated within an 
additional two months.   The Board of Appeal issues the final 
verdict on the validity of the contested European patent.  The whole 
challenge procedure at the EPO takes about three years adn the 
total costs of an opposition to an opponent or to the patentholder 
may range between Euro 15,000 and Euro 25,000 each, including 
fees for patent attorneys, fees for filing an opposition and an appeal 
against the outcome of opposition. 
 
Three examples of EPO Opposition 
 
1.  Corn plants with improved oil composition 
 
Oral proceedings are an integral part of the opposition proceedings 
provided for under the European Patent Convention, which allows 
anyone to object to a European patent. Oral proceedings at the 
European Patent Office in opposition proceedings relating to a 
DuPont patent for corn plants with improved oil composition, 
started in Munich on 12 February 2003.  The contested patent is 
  389European patent No. 744 888, entitled “Corn grains and products 
with improved oil composition”.  The oral proceedings are to 
decide whether the patent should be maintained, amended or 
revoked. Opposition has been lodged by the government of 
Mexico, Misereor (an overseas development agency of the Catholic 
Church in Germany), and Greenpeace Germany. Granted by the 
European Patent Office in August 2000, the patent concerned is 
valid in Italy, France and Spain, three of the 27 countries which 
make up the Member States of the European Patent Organisation. It 
relates to an invention in the field of plant biology which describes 
corn grains produced by cross-pollinating a male parent plant 
having a particularly high oil content with a female parent plant 
altered through chemical mutagenesis. The oil content of the 
grains, at least 55% of which must be oleic acid, is greater than 6%. 
The patent specification states that the maize plants used in the 
mutation breeding were developed at Iowa State University and the 
University of Illinois (USA).  
 
The opponents allege that the patent does not meet the 
requirements of Article 54 of the European Patent Convention 
(EPC), which governs the novelty of an invention. According to 
that article, an invention is considered to be new only if it does not 
form part of the state of the art. Public discussion has focused on 
whether maize having the characteristics described in the patent 
was already known, for example in Mexico.  An independent 
Opposition Division at the EPO is to decide on the case on the 
basis of the provisions of the EPC. 
 
2.  Revocation of “umbilical cord blood” patent upheld 
 
On 7 April 2003, a technical board of appeal of the European 
Patent Office (EPO) has upheld the revocation of the US firm 
Biocyte’s European patent describing inter alia the use of umbilical 
cord blood. The board ruled that the subject matter of the claims 
defended by the patent proprietor was not new vis-à-vis the state of 
the art and as such failed to meet the novelty requirement under 
Article 54 of the European Patent Convention.  Patent EP 343217 
had previously been revoked in EPO opposition proceedings in 
  3901999. The patent proprietor lodged an appeal against the opposition 
division's decision. 
 
3.  Outcome of oral proceedings relating to Monsanto patent, 
known as "Soya" patent 
 
The Opposition Division of the European Patent Office (EPO) 
came to the decision, on 6 May 2003 after a public hearing in 
opposition proceedings, of limiting the so-called “soya” patent 
owned by Monsanto (EP 301 749 B1).   Its title is “Particle-
mediated transformation of soybean plants and lines”.  In March 
1994, the EPO granted Agracetus, subsequently taken over by 
Monsanto, a patent for twelve of the current 27 member states of 
the European Patent Organisation. In its original form, the patent 
describes a process for genetically engineering plants, in particular 
soybean plants. 
 
The Opposition Division takes the view that the granted patent does 
not meet the requirement for sufficient disclosure. Under Article 83 
of the European Patent Convention (EPC), the description of an 
invention has to be sufficiently clear and complete for it to be 
carried out by a person skilled in the art. In its limited form, the 
patent now relates only to soybean plants, not generally to any kind 
of plant.  The parties can contest the outcome of the hearing in 
appeal proceedings before one of the EPO’s Technical Boards of 
Appeal. The reasons for the Opposition Division’s decision, setting 
out a full assessment of the facts and arguments, will be published 
at a later date. 
 
Increasing Scope of EPO 
 
A network of patent information centres comprising the national 
patent offices of the Member States of the European Patent 
Convention and all regional patent information centres, called 
PATLIB, provide information and competent advice for the public. 
In total, in over 280 such centres in Europe, one can find the 
addresses of patent information centres belonging to a selected list, 
provided by the appropriate national patent office. Where possible, 
the names of contact persons are given. The intention is not only 
  391that members of the public should be able to find their nearest 
patent information centre but also that the centres themselves will 
be able to contact their counterparts in different regions or even 
different countries.  
 
The European Patent Office (EPO) strengthened its presence in 
Brussels by opening a new office in this capital city of the 
European Union.  The President of the European Patent Office, 
speaking at the opening event, stated: “Patents seek to protect 
innovation and to encourage further innovation. The creation of this 
new bureau is the result of the EPO’s policy of increased 
cooperation with EU institutions, with the aim of promoting the 
European patent system in Europe and increasing the role of 
patents in the internal market”.  To demonstrate the common nature 
of patents in our everyday lives, the EPO points out that the 
average citizen makes use of some 300 patented objects or 
inventions (telephones, kitchenware, etc.) every day. The EPO 
received  about  165,000  applications  in  2002.   Presently, the  
top  three  areas of patented inventions are: medical technology  
and pharmaceuticals; computer related inventions; and, 
telecommunications. 
 
European Community Efforts 
 
The EU Competitiveness Council has stated that the EPO will have 
the central role in the grant procedure of the forthcoming 
Community patent, which will exist in parallel to European patents 
granted under the EPC and to national patents.   The EPC forms 
part of the acquis communautaire and the EPO’s enlargement in 
2002 from 20 to 27 countries parallels the forthcoming enlargement 
of the EU. 
 
With the First Action Plan for Innovation in Europe
5,  the 
Commission deemed it essential to gain as full a picture as possible 
of the patent system in Europe. The objective was to assess whether 
the existing patent system met the needs of users, examine whether 
                                                 
5 Presented by the Commission on 20 November 1996 COM (96) 589 final. 
 
  392new Community measures were necessary and consider what such 
measures could involve and what form they could take. Strategic 
discussions began at Community level on innovation and how to 
protect it and on its effects on employment. The Commission also 
prepared a Green Paper on the Community Patent and the Patent 
System in Europe
6.  
 
The Green Paper tackled the shortcomings resulting from the 
absence of the Community dimension in the European patent 
system and the obstacles preventing the Community system from 
coming into operation.  It also looked into the related technical, 
legal and political questions, such as further harmonization of 
certain aspects of patent law that could be necessary at Community 
level; and the impact of the information society and electronic 
commerce on software-related inventions, involving the use of 
patent protection. In order to improve the situation that European 
industry faces with respect to the development of the information 
society and electronic commerce, the Commission issued a 
communication entitled “A European initiative in electronic 
commerce”.
7   
 
The national patent law governing patentability, validity and the 
extent of protection, which existed historically in each one of the 
Member States of the European Community, was harmonized de 
facto as all the Member States acceded to the 1973 Munich 
Convention on the European Patent
8. The European Patent system 
is based on two international agreements, the 1973 European Patent 
                                                 
6 Green Paper on Innovation (COM (95) 688 final, 20.12.1995.   
7 COM (97) 157 final 16.4.1997. 
8  The Convention on the Grant of European Patents (EPC) was enacted in 
Munich on 5 October 1973 and entered into force on 7 October 1977. It is the 
legal foundation for the establishment of the European Patent Organization 
(EPO), which is an intergovernmental body, and is independent of the European 
Union. The full text of the Convention is available at http://www3.european-
patent-office.org/dwld/epc/epc_2000.pdf).   
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Community Patent, which is an integral part of the later Agreement 
Relating to Community Patents
9. The efforts towards creating a 
single Community patent have culminated in a Draft Regulation in 
2000
10.  
  
The Community Patent is intended to bring together the bundle of 
protection rights resulting from the grant of a European patent and 
create a single, unitary and autonomous protection right valid 
throughout all the Member States of the EU.  The objective of the 
Community patent is the full achievement of the aims of the single 
market, with special reference to fair competition and the free 
movement of goods. In accordance with Article 235 of the EC 
Treaty, the creation of a new Community system of patent 
protection by means of a Regulation requires unanimity, in turn 
necessitating a consensus between the Member States on all the 
technical issues involved. 
 
In the early days, the Community’s competence in the field of 
intellectual property rights was not clearly established.  However, 
the Court of Justice of the European Communities has recognized 
that the Community is competent to take action in the field of 
patents if this contributes to the attainment of one of the two major 
objectives of the Treaty: the free movement of goods and a system 
ensuring that competition is not distorted
11.     
 
                                                 
9 Agreement Relating to Community Patents, done at Luxembourg on 15 
December 1989 (OJ No. L. 401, 30.12.1989, p.1). 
10 Proposal for a Council Regulation on the Community Patent, COM (2000) 412 
final, 2000/0177 (CNS), Commission of the European Communities, Brussels, 
1.8.2000. 
11 In Case C-350/92 Spain v Council [1995] ECR 1-1985, the Court’s judgment 
of 13 July 1995, paragraph 27; its Opinion 1/94 of 15 November 1994 [1994] 
ECR 1-5267: (request was submitted by the Commission for an opinion on 
whether or not the Community had exclusive competence to conclude the GATT 
Agreements). 
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Regulation once adopted will simplify matters greatly since the 
Regulation will automatically form part of the acquis 
communautaire and will not have to be amended or renegotiated 
through the process of accepting new Member States into the 
Union.  The Community patent system, once it goes into operation, 
will have the essential feature of granting patents with a unitary 
character that will have equal effect throughout the Community and 
can be granted, transferred, revoked or allowed to lapse in respect 
of the whole of the Community.  It will also offer greater legal 
certainty through the creation of a central court competent to hand 
down decisions on interpretation and validity of Community 
patents. 
 
There is still the problem of the extremely high translation costs 
due to the need to have the entire patent specification translated 
into the languages of all the Member States.  The cost of translating 
the Community patent specification into all Community languages 
constitutes a major stumbling-block to the success of the 
Community patent. One solution is to limit the translation 
requirement to the patent claims only, either at the time the patent 
was granted or shortly afterwards. This limited translation 
requirement is extended by means of a reservation, whereby any 
Member State can declare that, if the patent specification was not 
published in one of the official languages of that State, the 
proprietor of the patent can not avail himself in that State of the 
rights conferred by the patent.  Any contracting state also has the 
right to demand a translation of the patent specification, the 
proprietor of the patent being free to decide when to file the 
translation, according to his protection needs. 
 
This solution enables the patentee to decide how urgently he needs 
protection in a particular Member State and allows him flexibility 
in choosing the point when he files a translation of the patent 
specification. The provision draws a distinction between cases 
where the patentee files the translation of the patent specification 
within three months of the date of publication of the mention of the 
grant of the patent, more than three months but less than three years 
later, or after three years have elapsed. In the first case, the patentee 
  395can avail himself of the rights conferred by the patent as soon as 
the translation is filed.  In the second case, he can do so from the 
same point in time but, in respect of use of the invention without 
his consent before the translation is filed, he can avail himself of 
the rights conferred by the patent only to the extent of claiming 
reasonable compensation.  In the third case, any person who has 
used or made effective and serious preparations for using the 
invention before the translation is filed may continue to use it on 
reasonable terms. 
 
Even when the Community patent is created, bringing a unitary 
system conferring rights that can be relied on throughout the 
Community, the European patent will still retain its usefulness.  In 
addition to the possible need for protection in certain countries that 
are not Member States of the European Community, the European 
Patent will also enable the firm concerned to designate certain 
countries and not necessarily all the Member States.  There is 
undoubtedly a need for some flexibility in the patent system in 
Europe, and this could be achieved by establishing links between 
the Community Patent and the European Patent.  
 
Conclusion         
             
Patents play an important role in protecting innovation, which is 
the driving force behind economic growth, creation of jobs and 
keeping up with global competition.  The mission of the EPO is to 
support innovation, competitiveness and economic growth by 
granting European patents for inventions. Under the European 
Patent Convention (EPC), the EPO administers a centralized patent 
grant system on behalf of all contracting states and is a model of 
successful co-operation in Europe.  The Convention establishes a 
single procedure for the grant of patents, which once granted, are 
subject to the national rules of the Contracting States designated in 
the application.  Nevertheless, there has occurred de facto 
harmonization of the provisions of national patent law governing 
patentability, validity and the extent of protection. 
 
The European patent is giving ample satisfaction both in terms of 
the calibre of the work carried out by the European Patent Office 
  396and in terms of the value of the protection right which it confers, as 
well as the EPO opposition procedure which functions effectively. 
The current 27 member countries of the European Patent 
Organization should be expanded to include many of the countries 
in the Euro-Mediterranean region as well. 
 
The current structure of the patent protection system in Europe is 
such that the European Patent Office is an international 
organization set up by treaty and is therefore independent of the 
European Union and any of its institutions.  A unitary Community 
patent needs to be incorporated within the EPO, in order to 
overcome some of the limitations for the successful operation of 
the Single Market. The patent system in Europe does not present a 
unitary picture, with national patents existing alongside European 
patents and a Community patent system which is yet to come into 
operation. 
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